Cytotoxic T lymphocyte antigen-4 (CTLA-4) limits the expansion of encephalitogenic T cells in experimental autoimmune encephalomyelitis (EAE)-resistant BALB/c mice

被引:59
作者
Hurwitz, AA
Sullivan, TJ
Sobel, RA
Allison, JP
机构
[1] Univ Calif Berkeley, Dept Mol & Cell Biol, Canc Res Lab, Berkeley, CA 94720 USA
[2] Univ Calif Berkeley, Howard Hughes Med Inst, Berkeley, CA 94720 USA
[3] SUNY Upstate Med Univ, Dept Microbiol & Immunol, Syracuse, NY 13210 USA
[4] Stanford Univ, Sch Med, Dept Pathol, Palo Alto, CA 94304 USA
[5] Vet Affairs Med Ctr, Lab Serv, Palo Alto, CA 94304 USA
关键词
susceptibility; tolerance; T helper 1 cells;
D O I
10.1073/pnas.042684699
中图分类号
O [数理科学和化学]; P [天文学、地球科学]; Q [生物科学]; N [自然科学总论];
学科分类号
07 ; 0710 ; 09 ;
摘要
We and others previously reported that cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the severity of peptide-induced experimental autoimmune encephalomyelitis (EAE) in mouse strains that are inherently susceptible to the disease. In this report, we show that CTLA-4 engagement also controls disease susceptibility in BALB/c mice, a strain considered to be resistant to EAE induction. Although immunization of BALB/c mice with syngeneic spinal cord homogenate or an I-Ad-binding myelin peptide antigen failed to result in EAE, immunization with either antigen preparation in conjunction with anti-CTLA-4 resulted in both clinical and histological EAE. CTLA-4 blockade also resulted in a preferential increase in the frequency of antigen-specific T cells secreting IFN-gamma. We conclude that CTLA-4 controls susceptibility in BALB/c mice by limiting the expansion of autoreactive T cells present in the periphery, suggesting a mechanism whereby CTLA-4 contributes to the maintenance of peripheral T cell tolerance to self antigens.
引用
收藏
页码:3013 / 3017
页数:5
相关论文
共 30 条
[11]  
Encinas JA, 1996, J IMMUNOL, V157, P2186
[12]   CTLA-4 gene polymorphism may modulate disease in Japanese multiple sclerosis patients [J].
Fukazawa, T ;
Yanagawa, T ;
Kikuchi, S ;
Yabe, I ;
Sasaki, H ;
Hamada, T ;
Miyasaka, K ;
Gomi, K ;
Tashiro, K .
JOURNAL OF THE NEUROLOGICAL SCIENCES, 1999, 171 (01) :49-55
[13]  
Greer JM, 1996, J IMMUNOL, V156, P371
[14]  
Harbo HF, 1999, TISSUE ANTIGENS, V53, P106
[15]   Specific blockade of CTLA-4/B7 interactions results in exacerbated clinical and histologic disease in an actively-induced model of experimental allergic encephalomyelitis [J].
Hurwitz, AA ;
Sullivan, TJ ;
Krummel, MF ;
Sobel, RA ;
Allison, JP .
JOURNAL OF NEUROIMMUNOLOGY, 1997, 73 (1-2) :57-62
[16]   CTLA-4: A negative regulator of autoimmune disease [J].
Karandikar, NJ ;
Vanderlugt, CL ;
Walunas, TL ;
Miller, SD ;
Bluestone, JA .
JOURNAL OF EXPERIMENTAL MEDICINE, 1996, 184 (02) :783-788
[17]   ACUTE EXPERIMENTAL ALLERGIC ENCEPHALOMYELITIS IN RADIATION BONE-MARROW CHIMERAS BETWEEN HIGH AND LOW SUSCEPTIBLE STRAINS OF MICE [J].
KORNGOLD, R ;
FELDMAN, A ;
RORKE, LB ;
LUBLIN, FD ;
DOHERTY, PC .
IMMUNOGENETICS, 1986, 24 (05) :309-315
[18]   Cytotoxic T lymphocyte antigen-4 (CTLA-4) regulates the size, reactivity, and function of a primed pool of CD4+ T cells [J].
Kuhns, MS ;
Epshteyn, V ;
Sobel, RA ;
Allison, LP .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2000, 97 (23) :12711-12716
[19]   The CTLA-4 gene is associated with multiple sclerosis [J].
Ligers, A ;
Xu, C ;
Saarinen, S ;
Hillert, J ;
Olerup, O .
JOURNAL OF NEUROIMMUNOLOGY, 1999, 97 (1-2) :182-190
[20]  
Matsui T, 1999, J IMMUNOL, V162, P4328